Ceryvyn Therapeutics Limited

OTCPK:OPTE.Y Stock Report

Market Cap: US$13.3m

Ceryvyn Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:OPTE.Y Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
05 Jun 26SellUS$588,455Regal Partners LimitedCompany56,544,333US$0.011
03 Jun 26SellUS$12,062,266Regal Partners LimitedCompany136,882,989US$0.088

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of OPTE.Y?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders29,621,5062.17%
Private Companies91,508,1846.69%
VC/PE Firms96,466,5917.05%
Institutions271,228,25919.8%
General Public879,153,63364.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 35.71% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
7.05%
The Carlyle Group Inc.
96,466,591US$936.2k0%0.01%
4.58%
BNY Asset Management
62,630,265US$607.8k-28.1%no data
4.42%
Regal Partners Limited
60,496,074US$587.1k-81.1%0.02%
4.29%
JPMorgan Chase & Co.
58,741,221US$570.1k0%no data
3.81%
JAF Capital Pty Ltd
52,134,108US$505.9k0%no data
2.51%
Vanguard Capital Management, LLC
34,379,781US$333.6k0%no data
1.46%
Vanguard Investments Australia Limited
20,004,594US$194.1k0%no data
1.32%
Information Logistics Pty Ltd
18,076,530US$175.4k0%no data
1.02%
David Thurin
14,004,711US$135.9k0%no data
0.98%
Jeremy Levin
13,421,496US$130.3k21,200%no data
0.96%
M&S Skyleisure Pty Ltd
13,162,671US$127.7k0%no data
0.76%
Vanguard Fiduciary Trust Company
10,423,474US$101.2k0%no data
0.76%
Nt-Comnwlth Super Corp
10,336,919US$100.3k0%no data
0.59%
Safo Investments Pty Ltd
8,134,875US$78.9k0%no data
0.37%
Armada Trading Pty. Ltd.
5,005,806US$48.6k0%100.0%
0.19%
Pictet Asset Management Limited
2,588,760US$25.1k0%no data
0.17%
Charles Schwab Investment Management, Inc.
2,276,227US$22.1k-87.5%no data
0.15%
Katherine Connell
2,000,000US$19.4k0%no data
0.13%
Australian Super Pty Ltd
1,728,032US$16.8k0%no data
0.077%
Pictet Asset Management (Singapore) Pte Ltd
1,052,247US$10.2k0%0.02%
0.03%
JP Morgan Asset Management
414,159US$4.0k0%no data
0.021%
Vanguard Asset Management, Limited
291,317US$2.8k0%no data
0.018%
Norges Bank Investment Management
244,774US$2.4k0%no data
0.017%
Vanguard Global Advisers, LLC
232,395US$2.3k0%no data
0.015%
American Century Investment Management Inc
200,476US$1.9k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/07 15:59
End of Day Share Price 2026/07/07 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Ceryvyn Therapeutics Limited is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Elyse ShapiroCanaccord Genuity
John SavinEdison Investment Research
Chris CooperGoldman Sachs